News

Daiichi Sankyo said that the Engage AF-TIMI 48 study began enrollment in November 2008. The Phase III Engage AF-TIMI 48 clinical study is an event-driven, randomised, double-blind, double-dummy,

Ulipristal acetate is an orally active selective progesterone receptor modulator that reversibly blocks the progesterone receptors in targeted tissues. HRA Pharma has been developing ulipristal acetate for a

Global Health said Relax-B is the sublingual formulation of Propranolol currently marketed for hypertension and it has decided to develop a rapid absorption formulation using their proprietary sublingual

AMT and Amgen claim that the GDNF gene contains the information to produce a protein necessary for the development and survival of nerve cells. According to AMT, the

Specifically, the Therapex Division of E-Z-EM Canada, a wholly-owned subsidiary of Bracco Pharma in Italy, will manufacture the product for Apricus Bio. Apricus said Therapex will also be

Nanjing MeiRui is the operating entity of Pagoda Pharma Group, a British Virgin Islands-based holding company that established the Chinese health-care company in 1996. Branded drugmakers, including GSK,

The UK drug maker acquired SRT501, a proprietary formulation of resveratrol, a substance found in grapes and red wine, from biotech company Sirtris Pharmaceuticals, as part of the

Ezogabine is an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures. A CRL is issued by the FDA’s Center for Drug Evaluation

The transaction, latest in a series of biotech deals by major drug firms facing the prospect of patent cliff for their blockbuster drugs, will exceed $500m if several